Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's Disease
NCT02999997, Not applicable, Completed, University Hospital, Linkoeping
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's Disease | ClinicalTrials.gov |
| NCT number | NCT02999997 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 51 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University Hospital, Linkoeping | ClinicalTrials.gov |
| Conditions | Parkinson Disease | ClinicalTrials.gov |
| Interventions | Ronnie Gardiner Method (RGM) | ClinicalTrials.gov |
| First posted | 2016-12-21 | ClinicalTrials.gov |
| Last updated | 2018-05-02 | ClinicalTrials.gov |
Registered outcomes 19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Timed Up and Go Cognitive (TUGcog) (motor-cognitive dual task) | Change from Baseline through study completion (at 12 weeks) and at 3 months | Time in seconds to complete the following sequence: stand up from a chair, walk 3 meters, turn, walk back to the chair and sit down with the addition of counting backwards with 7 from 100, 90, 80, 70, 60, or 50. Number of errors are noted. Higher speed indicated better function. | ClinicalTrials.gov |
| Primary | Timed Up and Go manual (TUG manual) (motor-motor dual task) | Change from Baseline through study completion (at 12 weeks) and at 3 months | Time in seconds to complete the following sequence: stand up from a chair, walk 3 meters, turn, walk back to the chair and sit down with the additional task to carry a tray with two glasses of water. Higher speed indicates better function. | ClinicalTrials.gov |
| Secondary | Dual-task cost (DTC) | Change from Baseline through study completion (at 12 weeks) and at 3 months | Measuring the difference between Timed Up and Go (TUG) single task and TUG cognitive and manual respectively | ClinicalTrials.gov |
| Secondary | Mini-BESTest (Balance Evaluation Systems Test) | Change from Baseline through study completion (at 12 weeks) and at 3 months | A balance test focusing on dynamic balance and can be conducted in 10-15 minutes. | ClinicalTrials.gov |
| Secondary | Four Step Square Test, FSST | Change from Baseline through study completion (at 12 weeks) and at 3 months | Patient steps over four canes set-up like a cross on the floor with the tips of the canes facing together. At the start of the test, the patient stands on the upper left square (in Square 1, facing Square 2). The stepping sequence is (clockwise): Square 1, Square 2, Square 4, Square 3, return to Square 1 with the feet. Then (counterclockwise): Back to Square 3, Square 4, Square 2, and end in Square 1 with both feet. | ClinicalTrials.gov |
| Secondary | Berg Balance Scale | Change from Baseline through study completion (at 12 weeks) and at 3 months | Static and dynamic activities of varying difficulty are performed. Item-level scores range from 0-4, determined by ability to perform the assessed activity. Item scores are summed. Maximum score = 56 | ClinicalTrials.gov |
| Secondary | Chair stand 30 seconds | Change from Baseline through study completion (at 12 weeks) and at 3 months | Standing up and sitting down, hands crossed over chest, as many times as possible for 30 seconds. | ClinicalTrials.gov |
| Secondary | Montreal Cognitive Assessment (MoCA) | Change from Baseline through study completion (at 12 weeks) and at 3 months | Screening of cognitive function. License has been approved. | ClinicalTrials.gov |
| Secondary | Auditory memory test, direct and delayed | Change from Baseline through study completion (at 12 weeks) and at 3 months | A text is read to the patient. The patient is then required to reproduce the text as exactly as possible, and then again after appr. 10 minutes. | ClinicalTrials.gov |
| Secondary | Symbol Digit Modalities Test (SDMT) | Change from Baseline through study completion (at 12 weeks) and at 3 months | A code key is presented to the patient where each code key represents a number between 1 and 9. The patient is then required to solve as many codes as possible in 90 seconds. | ClinicalTrials.gov |
| Secondary | Victoria Stroop test | Change from Baseline through study completion (at 12 weeks) and at 3 months | Colored words are presented to the patient but in a different color than the word says, eg. the word BLUE appears in the color red and the patient is required to say "red", and not read the word "blue". | ClinicalTrials.gov |
| Secondary | Grooved Pegboard | Change from Baseline through study completion (at 12 weeks) and at 3 months | The patient is required to move a number of metal sticks from one side to another as fast as possible. A measure of fine motor control. | ClinicalTrials.gov |
| Secondary | Trail Making Test A and B | Change from Baseline through study completion (at 12 weeks) and at 3 months | The patient is required to draw a line between the numbers 1 to 25 (A), and between the numbers 1 to 13 and vary to the letters A to L, i.e. 1-A-2-B-3-C, etc, without lifting the pen from the paper. | ClinicalTrials.gov |
| Secondary | Rey complex figure | Change from Baseline through study completion (at 12 weeks) and at 3 months | The patient is required to copy a figure twice: the first time from a model in front of him/her; the second time without the model by memory only. | ClinicalTrials.gov |
| Secondary | WHODAS 2.0 | Baseline | A questionnaire based on the International Classification of Functioning (ICF) for assessing impairments and function. | ClinicalTrials.gov |
| Secondary | Freezing of gait questionnaire | Change from Baseline through study completion (at 12 weeks) and at 3 months | A questionnaire with questions about freezing of gait | ClinicalTrials.gov |
| Secondary | Parkinson's disease questionnaire 39 items (PDQ-39) | Change from Baseline through study completion (at 12 weeks) and at 3 months | A questionnaire for quality of life in people with Parkinson's disease. License as been approved. | ClinicalTrials.gov |
| Secondary | Falls Efficacy Scale International (FES-I) | Change from Baseline through study completion (at 12 weeks) and at 3 months | A questionnaire related to fear of falling. | ClinicalTrials.gov |
| Secondary | Actigraphy with GeneActiv Armband | Change from Baseline through study completion (at 12 weeks) and at 3 months | Actigraphy is a method to evaluate physical activity in a research person´s normal life. GeneActiv is used to record number of steps daily but also time spent lying and standing which will give information about the activity. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 2
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Complex Figure Copy and Recall | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)